The IPO Buzz: Apnimed (APMD) Prices Upsized IPO at $16 – High End – & Stock Opens at $22
Apnimed (APMD) took its IPO up a notch: The sleep apnea-focused biotech upsized its IPO to 12 million shares – up from 10 million in the prospectus – and priced its IPO at at $16.00 – the top of its range – to raise $192 million on Thursday night, July 30, 2026. Apnimed increased the number of shares by 20 percent. The IPO had been marketed at a price range of $14.00 to $16.00. ..
Read more July 30, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Apnimed | APMD | 12.0 | $ 192.0 mil | 7/31/2026 Priced | S/O | S/O |
| Churchill Capital XIII | XIIIU | 36.0 | $ 360.0 mil | 7/31/2026 Priced | S/O | S/O |
| East West Ave Acquisition Corp. | EWAVU | 10.0 | $ 100.0 mil | 7/31/2026 Priced | S/O | S/O |
Last 100 IPOs - August 1, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 56 |
| Number Down: | 40 |
| Number Unchanged: | 4 |
| Percentage Change From Issue Price: | 7.13% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - August 1, 2026
| Number of IPOs priced (Excluding 134 units) : | 104 |
| Number Up: | 58 |
| Number Down: | 42 |
| Number Unchanged: | 4 |
| Total Return From Issue Price: | 6.73% |
| The Nasdaq Composite Index YTD % Change | 35.22% |